All Stories

  1. Strongyloides stercoralis and Trypanosoma cruzi coinfections in a highly endemic area in Argentina
  2. The Strongyloides stercoralis-hookworms association as a path to the estimation of the global burden of strongyloidiasis: A systematic review
  3. Role of DNA-detection–based tools for monitoring the soil-transmitted helminth treatment response in drug-efficacy trials
  4. Ivermectin for the Treatment of Soil-Transmitted Helmithiases
  5. Challenges and opportunities for control and elimination of soil-transmitted helminth infection beyond 2020
  6. Strongyloidiasis
  7. Tegumentary leishmaniasis and sand flies in a border area between Argentina and Bolivia
  8. Molecular Identification of Leishmania spp. DNA from Archived Giemsa-Stained Slides of Patients from Salta, Argentina
  9. Misconceptions and paradoxes in soil-transmitted helminthiases control as a public health problem
  10. Toward the 2020 goal of soil-transmitted helminthiasis control and elimination
  11. Transrenal DNA-based diagnosis of Strongyloides stercoralis (Grassi, 1879) infection: Bayesian latent class modeling of test accuracy
  12. Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers
  13. Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers
  14. Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study
  15. Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina
  16. Serologic Monitoring of Public Health Interventions against Strongyloides stercoralis
  17. A novel, species-specific, real-time PCR assay for the detection of the emerging zoonotic parasite Ancylostoma ceylanicum in human stool
  18. High prevalence of Strongyloides stercoralis in school-aged children in a rural highland of north-western Ethiopia: the role of intensive diagnostic work-up
  19. Diagnosis of Strongyloides stercoralis: Detection of parasite-derived DNA in urine
  20. StrongNet: An International Network to Improve Diagnostics and Access to Treatment for Strongyloidiasis Control
  21. PHARMACOKINETICS OF BENZNIDAZOLE IN CHAGAS DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
  22. Spatial spread of dengue in a non-endemic tropical city in northern Argentina
  23. Epidemiology of American Tegumentary Leishmaniasis andTrypanosoma cruziInfection in the Northwestern Argentina
  24. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
  25. Effect of Poor Access to Water and Sanitation As Risk Factors for Soil-Transmitted Helminth Infection: Selectiveness by the Infective Route
  26. Identification of human intestinal parasites affecting an asymptomatic peri-urban Argentinian population using multi-parallel quantitative real-time polymerase chain reaction
  27. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
  28. Accuracy of Five Serologic Tests for the Follow up of Strongyloides stercoralis Infection
  29. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collabor...
  30. The Epidemiology of Human Strongyloidiasis
  31. Assessment of Anthelmintic Efficacy of Mebendazole in School Children in Six Countries Where Soil-Transmitted Helminths Are Endemic
  32. Diagnostic Accuracy of Five Serologic Tests for Strongyloides stercoralis Infection
  33. Mini-FLOTAC, Kato-Katz and McMaster: three methods, one goal; highlights from north Argentina
  34. Performance of differentTrypanosoma cruziantigens in the diagnosis of Chagas disease in patients with American cutaneous leishmaniasis from a co-endemic region in Argentina
  35. A Public Health Response against Strongyloides stercoralis: Time to Look at Soil-Transmitted Helminthiasis in Full
  36. Strongyloides stercoralis: A Plea for Action
  37. Restricted Outbreak of American Tegumentary Leishmaniasis with High Microfocal Transmission
  38. Estimation of HIV-Testing Rates to Maximize Early Diagnosis-Derived Benefits at the Individual and Population Level
  39. A phase 4, single-arm, open-label, pilot study of maraviroc, raltegravir and darunavir/r in HIV-1 adults with triple class failure: TERCETO study
  40. Development of a new platform for neglected tropical disease surveillance
  41. Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials
  42. Prioritizing CD4 Count Monitoring in Response to ART in Resource-Constrained Settings: A Retrospective Application of Prediction-Based Classification
  43. No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30days course of nitazoxanide monotherapy
  44. Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1st PI-Based Regimen
  45. Immuno-enzymatic evaluation of the recombinant TSSA-II protein of Trypanosoma cruzi in dogs and human sera: a tool for epidemiological studies
  46. Cancer in HIV-Infected Persons From the Caribbean, Central and South America
  47. Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters
  48. Improved Diagnosis of Strongyloides stercoralis Using Recombinant Antigen-Based Serologies in a Community-Wide Study in Northern Argentina
  49. Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America
  50. Urban Transmission of American Cutaneous Leishmaniasis in Argentina: Spatial Analysis Study
  51. Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean
  52. Use of darunavir and enfuvirtide in a pregnant woman
  53. Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in Patients with HIV Previously Receiving Episodic Therapy
  54. Inferior Clinical Outcome of the CD4+Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+Cell Counts and HIV RNA Levels during Follow‐up
  55. Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study
  56. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model
  57. Safe Treatment Interruptions in Patients With Nadir CD4 Counts of More Than 350 Cells/??L
  58. Human Immunoglobulin G Mediates Protective Immunity and Identifies Protective Antigens against LarvalStrongyloides stercoralisin Mice
  59. Efficacy of azithromycin in the treatment of cutaneous leishmaniasis
  60. Activity of azithromycin against Leishmania major in vitro and in vivo.
  61. Effect of Chronic Ethanol Consumption on Protective T-Helper 1 and T-Helper 2 Immune Responses Against the Parasites Leishmania major and Strongyloides stercoralis in Mice
  62. Effect of Chronic Ethanol Consumption on Protective T-Helper 1 and T-Helper 2 Immune Responses Against the Parasites Leishmania major and Strongyloides stercoralis in Mice
  63. Highly active antiretroviral therapy does not protect against Kaposi's sarcoma in HIV-infected individuals
  64. More on Continuous-Infusion Acyclovir for Severe Varicella